ΔΎΉΟΦ±²₯

Meeting Coverage

ASH Future Focus: Multiple Myeloma

Future Focus from the American Society of Hematology

Mezigdomide Combinations Show Promise in Multiple Myeloma

High rates of durable response in difficult-to-treat disease, with good tolerability

image

Latest ASH Future Focus: Multiple Myeloma Meeting Coverage

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

Rapid evaluation and novel therapies may improve outcomes for these patients

December 23, 2024
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

Study links strong relationships to better physical and emotional outcomes in myeloma care

December 20, 2024
Pain, Fatigue Benefits May Give Resistance Training a Leg Up in Multiple Myeloma

Structured exercise improves fatigue and pain but requires long-term patient commitment

December 16, 2024